TFF Pharmaceuticals, Inc. Common Stock
TFFP
TFFP was delisted on the 12th of December, 2024.
21 hedge funds and large institutions have $1.07M invested in TFF Pharmaceuticals, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
11% more funds holding
Funds holding: 19 → 21 (+2)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
50% less capital invested
Capital invested by funds: $2.12M → $1.07M (-$1.05M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$487K |
| 2 |
CC
Carlson Capital
Dallas,
Texas
|
+$261K |
| 3 |
WIM
Westside Investment Management
Santa Monica,
California
|
+$29.6K |
| 4 |
NL
NWAM LLC
Mercer Island,
Washington
|
+$26.9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$11.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$59.3K |
| 2 |
NFSG
Newbridge Financial Services Group
Boca Raton,
Florida
|
-$2.62K |
| 3 |
BlackRock
New York
|
-$1.61K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.03K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$868 |
TFFP Hedge Fund Activity: Q2 2024 in Review
21 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in TFF Pharmaceuticals, Inc. Common Stock (TFFP) for Q2 2024, worth a combined $1.07M — down 50% from $2.12M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TFFP positions and 2 closed out — a net gain of 2 holders — while 5 added to existing stakes and 6 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $487K. The largest seller was Vanguard Group, cutting an estimated $59.3K.
- 21 institutional investors held TFF Pharmaceuticals, Inc. Common Stock (TFFP) as of Q2 2024, up from 19 in Q1 2024.
- Funds reported $1.07M of TFF Pharmaceuticals, Inc. Common Stock stock for Q2 2024, down 50% quarter-over-quarter.
- 4 funds opened new TFF Pharmaceuticals, Inc. Common Stock positions in Q2 2024 and 2 closed out, a net change of +2 holders.
- The largest TFF Pharmaceuticals, Inc. Common Stock buyer in Q2 2024 was Armistice Capital, an estimated $487K added.
- The largest TFF Pharmaceuticals, Inc. Common Stock seller in Q2 2024 was Vanguard Group, an estimated $59.3K sold.
Based on aggregated 13F filings for Q2 2024.